Phocas Financial »

Cytokinetics shares owned by Phocas Financial

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Phocas Financial from 13F filings

Historical chart of Phocas Financial investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Phocas Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Phocas Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.1M 25k 85.19

More positions owned by Phocas Financial

Ducommun Incorporated (DCO)
Amneal Pharmaceuticals Com Stk Cl A (AMRX)
Aar (AIR)
Materion Corporation (MTRN)
Stonex Group (SNEX)
Ralliant Corp (RAL)
Wintrust Financial Corporation (WTFC)
National Energy Services Reu SHS (NESR)
Ameris Ban (ABCB)
Columbia Banking System (COLB)
Alerus Finl (ALRS)
Meta Financial (CASH)
Carpenter Technology Corporation (CRS)
SkyWest (SKYW)
Preferred Bk Los Angeles Ca Com New (PFBC)

View all positions for Phocas Financial

Top funds holding Cytokinetics

BlackRock
Wellington Management Company
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
FMR
venBio Select Advisor
Bank of America Corporation
Susquehanna International
Geode Capital Management
Rtw Investments
Armistice Capital
Polar Capital Holdings
Citadel Advisors
Goldman Sachs Group

View all funds holding Cytokinetics